Two Sigma Advisers’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,100
| Closed | -$98.9K | – | 2425 |
|
|
2023
Q2 | $98.9K | Sell |
27,100
-6,000
| -18% | -$21.9K | ﹤0.01% | 2217 |
|
|
2023
Q1 | $118K | Sell |
33,100
-75,800
| -70% | -$271K | ﹤0.01% | 2359 |
|
|
2022
Q4 | $310K | Sell |
108,900
-74,400
| -41% | -$212K | ﹤0.01% | 2058 |
|
|
2022
Q3 | $409K | Sell |
183,300
-30,800
| -14% | -$68.7K | ﹤0.01% | 1928 |
|
|
2022
Q2 | $533K | Buy |
214,100
+8,600
| +4% | +$21.4K | ﹤0.01% | 1889 |
|
|
2022
Q1 | $1M | Sell |
205,500
-21,700
| -10% | -$106K | ﹤0.01% | 1637 |
|
|
2021
Q4 | $2.57M | Buy |
227,200
+25,200
| +12% | +$285K | 0.01% | 1064 |
|
|
2021
Q3 | $2.94M | Sell |
202,000
-96,000
| -32% | -$1.4M | 0.01% | 1047 |
|
|
2021
Q2 | $3.47M | Sell |
298,000
-68,100
| -19% | -$793K | 0.01% | 1035 |
|
|
2021
Q1 | $4.47M | Buy |
366,100
+15,400
| +4% | +$188K | 0.01% | 895 |
|
|
2020
Q4 | $4.39M | Buy |
350,700
+57,300
| +20% | +$717K | 0.01% | 878 |
|
|
2020
Q3 | $4.42M | Buy |
293,400
+155,800
| +113% | +$2.34M | 0.01% | 809 |
|
|
2020
Q2 | $3.37M | Buy |
137,600
+127,000
| +1,198% | +$3.11M | 0.01% | 960 |
|
|
2020
Q1 | $150K | Buy |
+10,600
| New | +$150K | ﹤0.01% | 2236 |
|